Fc Variants With Altered Binding To Fcrn - EP3138853

The patent EP3138853 was granted to Xencor on Nov 24, 2021. The application was originally filed on Sep 22, 2008 under application number EP16185391A. The patent is currently recorded with a legal status of "Revoked".

EP3138853

XENCOR
Application Number
EP16185391A
Filing Date
Sep 22, 2008
Status
Revoked
May 5, 2023
Grant Date
Nov 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBAug 24, 2022ADMISSIBLE

Patent Citations (113) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20000222697-
DESCRIPTIONUS20010782004-
DESCRIPTIONUS20010810510-
DESCRIPTIONUS20010903378-
DESCRIPTIONUS20010927790-
DESCRIPTIONUS20020039170-
DESCRIPTIONUS20020101499-
DESCRIPTIONUS20020113929-
DESCRIPTIONUS20020172317-
DESCRIPTIONUS20020218102-
DESCRIPTIONUS20020277370-
DESCRIPTIONUS20030379392-
DESCRIPTIONUS20030666307-
DESCRIPTIONUS20030666311-
DESCRIPTIONUS20030672280-
DESCRIPTIONUS20040754296-
DESCRIPTIONUS20040822231-
DESCRIPTIONUS20050124620-
DESCRIPTIONUS20050124640-
DESCRIPTIONUS20050174287-
DESCRIPTIONUS20050256060-
DESCRIPTIONUS20060396495-
DESCRIPTIONUS20080459004-
DESCRIPTIONWO2003US40426-
DESCRIPTIONUS2003050331
DESCRIPTIONUS2004214988
DESCRIPTIONUS2005114037
DESCRIPTIONUS2006067930
DESCRIPTIONUS3691016
DESCRIPTIONUS3969287
DESCRIPTIONUS4179337
DESCRIPTIONUS4195128
DESCRIPTIONUS4229537
DESCRIPTIONUS4247642
DESCRIPTIONUS4301144
DESCRIPTIONUS4330440
DESCRIPTIONUS4496689
DESCRIPTIONUS4640835
DESCRIPTIONUS4670417
DESCRIPTIONUS4753894
DESCRIPTIONUS4791192
DESCRIPTIONUS4943533
DESCRIPTIONUS5292658
DESCRIPTIONUS5418155
DESCRIPTIONUS5500362
DESCRIPTIONUS5530101
DESCRIPTIONUS5558864
DESCRIPTIONUS5585089
DESCRIPTIONUS5677171
DESCRIPTIONUS5683888
DESCRIPTIONUS5693761
DESCRIPTIONUS5693762
DESCRIPTIONUS5736137
DESCRIPTIONUS5741668
DESCRIPTIONUS5777079
DESCRIPTIONUS5804387
DESCRIPTIONUS5821337
DESCRIPTIONUS5859205
DESCRIPTIONUS5874304
DESCRIPTIONUS5876995
DESCRIPTIONUS5891996
DESCRIPTIONUS5925558
DESCRIPTIONUS6054297
DESCRIPTIONUS6180370
DESCRIPTIONUS6188965
DESCRIPTIONUS6235883
DESCRIPTIONUS6269312
DESCRIPTIONUS6403312
DESCRIPTIONUS6407213
DESCRIPTIONUS6506883
DESCRIPTIONUS6586207
DESCRIPTIONUS6602684
DESCRIPTIONUS6737056
DESCRIPTIONUS6792356
DESCRIPTIONUS6801861
DESCRIPTIONUS6804611
DESCRIPTIONUS6950754
DESCRIPTIONWO0003317
DESCRIPTIONWO0061739
DESCRIPTIONWO0121823
DESCRIPTIONWO0129246
DESCRIPTIONWO0162931
DESCRIPTIONWO0188138
DESCRIPTIONWO02069232
DESCRIPTIONWO02077187
DESCRIPTIONWO02079232
DESCRIPTIONWO02100165
DESCRIPTIONWO0230954
DESCRIPTIONWO0231140
DESCRIPTIONWO03011161
DESCRIPTIONWO03073238
DESCRIPTIONWO2005035727
DESCRIPTIONWO2005074524
DESCRIPTIONWO2009058492
DESCRIPTIONWO8705330
DESCRIPTIONWO9211018
DESCRIPTIONWO9215673
DESCRIPTIONWO9413804
DESCRIPTIONWO9507463
DESCRIPTIONWO9520045
DESCRIPTIONWO9640210
DESCRIPTIONWO9814605
DESCRIPTIONWO9826277
DESCRIPTIONWO9848032
DESCRIPTIONWO9852976
DESCRIPTIONWO9859244
DESCRIPTIONWO9949019
OPPOSITIONUS7217797
OPPOSITIONWO2006053301
SEARCHWO2006031370
SEARCHWO2006053301
SEARCHWO2006076594
SEARCHWO2008048545

Non-Patent Literature (NPL) Citations (162) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ANDERSON ET AL., PROC NATL ACAD SCI USA, (2004), vol. 101, no. 2, pages 7566 - 71-
DESCRIPTION- APLIN; WRISTON, CRC CRIT. REV. BIOCHEM., (1981), pages 259 - 306-
DESCRIPTION- ASHKENAZI, CURR OPIN IMMUNOL, (1997), vol. 9, pages 195 - 200-
DESCRIPTION- ASHKENAZI ET AL., CURR OPIN IMMUNOL, (1997), vol. 9, pages 195 - 200-
DESCRIPTION- BACA ET AL., J. BIOL. CHEM., (1997), vol. 272, no. 16, pages 10678 - 10684-
DESCRIPTION- BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426-
DESCRIPTION- BURMEISTER ET AL., NATURE, (1994), vol. 372, pages 379 - 383-
DESCRIPTION- CARTER ET AL., PROC NATL ACAD SCI USA, (1992), vol. 89, pages 4285 - 9-
DESCRIPTION- CARTRON ET AL., BLOOD, (2002), vol. 99, pages 754 - 758-
DESCRIPTION- CHALFIE ET AL., SCIENCE, (1994), vol. 263, pages 802 - 805-
DESCRIPTION- CHAMOW ET AL., TRENDS BIOTECHNOL, (1996), vol. 14, pages 52 - 60-
DESCRIPTION- "chapter 1", VAN HOLDE; JOHNSON; HO, Principles of Physical Biochemistry, PRENTICE HALL, (1998), pages 2 - 67-
DESCRIPTION- CHIN ET AL., SCIENCE, (2003), vol. 301, no. 5635, pages 964 - 7-
DESCRIPTION- CLARK, IMMUNOL TODAY, (2000), vol. 21, pages 397 - 402-
DESCRIPTION- CLYNES ET AL., NAT MED, (2000), vol. 6, pages 443 - 446-
DESCRIPTION- CLYNES ET AL., PROC NATL ACAD SCI USA, (1998), vol. 95, pages 652 - 656-
DESCRIPTION- COBLEIGH ET AL., J CLIN ONCO, (1999), vol. 17, pages 2639 - 2648-
DESCRIPTION- CRAGG, CURR OPIN IMMUNOL, (1999), vol. 11, pages 541 - 547-
DESCRIPTION- CROPP; SHULTZ, TRENDS GENET, (2004), vol. 20, no. 12, pages 625 - 30-
DESCRIPTION- Current Protocols in Molecular Biology, JOHN WILEY & SONS-
DESCRIPTION- DAHIYAT; MAYO, PROTEIN SCI., (199605), vol. 5, no. 5, pages 895 - 903-
DESCRIPTION- DALL' ACQUA ET AL., J. IMMUNOL., (2002), vol. 169, pages 5171 - 5180-
DESCRIPTION- DALL' ACQUA ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, (20060818), vol. 281, no. 33, pages 23514 - 24-
DESCRIPTION- DALL' ACQUA ET AL., JOURNAL OF IMMUNOLOGY, (2002), vol. 169, pages 5171 - 5180-
DESCRIPTION- DAVIES ET AL., BIOTECHNOL BIOENG, (2001), vol. 74, pages 288 - 294-
DESCRIPTION- DAVIS ET AL., IMMUNOLOGICAL REVIEWS, (2002), vol. 190, pages 123 - 136-
DESCRIPTION- DAVIS ET AL., IMMUNOL. REVIEWS, (2002), vol. 190, pages 123 - 136-
DESCRIPTION- DEECHONGKIT ET AL., J AM CHEM SOC., (2004), vol. 126, no. 51, pages 16762 - 71-
DESCRIPTION- DEISENHOFER, BIOCHEMISTRY, (1981), vol. 20, pages 2361 - 2370-
DESCRIPTION- DELANO ET AL., SCIENCE, (2000), vol. 287, pages 1279 - 1283-
DESCRIPTION- DE PASCALIS ET AL., J. IMMUNOL., (2002), vol. 169, pages 3076 - 3084-
DESCRIPTION- DUSKIN ET AL., J. BIOL. CHEM., (1982), vol. 257, page 3105-
DESCRIPTION- E.A. KABAT, SEQUENCES OF IMMUNOLOGICAL INTEREST, 5th ed., NIH PUBLICATION, NO. 91-3242-
DESCRIPTION- EDELMAN ET AL., PROC NATL ACAD SCI USA, (1969), vol. 63, pages 78 - 85-
DESCRIPTION- EDGE ET AL., ANAL. BIOCHEM., (1981), vol. 118, page 131-
DESCRIPTION- EHRLICH ET AL., HUM. ANTIBODIES HYBRIDOMAS, (1992), vol. 3, pages 2 - 7-
DESCRIPTION- GARMAN ET AL., NATURE, (2000), vol. 406, pages 259 - 266-
DESCRIPTION- GHETIE ET AL., ANNU REV IMMUNOL, (2000), vol. 18, pages 739 - 766-
DESCRIPTION- GHETIE ET AL., NAT. BIOTECH., (1997), vol. 15, no. 7, pages 637 - 640-
DESCRIPTION- GHETIE; WARD, ANNU. REV. IMMUNOL., (2000), vol. 18, pages 739 - 766-
DESCRIPTION- GHETIE; WARD, IMMUNOL TODAY, (1997), vol. 18, no. 12, pages 592 - 598-
DESCRIPTION- GLENNIE ET AL., IMMUNOL TODAY, (2000), vol. 21, pages 403 - 410-
DESCRIPTION- GORMAN ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, pages 4181 - 4185-
DESCRIPTION- HAKIMUDDIN ET AL., ARCH. BIOCHEM. BIOPHYS., (1987), vol. 259, page 52-
DESCRIPTION- HALE ET AL., TISSUE ANTIGENS, (1990), vol. 35, pages 118 - 127-
DESCRIPTION- HALE, TISSUE ANTIGENS, (1990), vol. 35, pages 118 - 127-
DESCRIPTION- HAMMER, J. EXP. MED., (1994), vol. 180, pages 2353 - 2358-
DESCRIPTION- HAYHURST; GEORGIOU, CURR OPIN CHEM BIOL, (2001), vol. 5, pages 683 - 689-
DESCRIPTION- HE ET AL., J. IMMUNOL., (1998), vol. 160, pages 1029 - 1035-
DESCRIPTION- HEIM ET AL., CURR. BIOL., (1996), vol. 6, pages 178 - 182-
DESCRIPTION- HINTON ET AL., J. BIOL. CHEM., (2004), vol. 279, no. 8, pages 6213 - 6216-
DESCRIPTION- HINTON ET AL., JOUNAL OF IMMUNOLOGY, (2006), vol. 176, pages 346 - 356-
DESCRIPTION- HINTON ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, (2004), vol. 279, no. 8, pages 6213 - 6216-
DESCRIPTION- HINTON ET AL., JOURNAL OF IMMUNOLOGY, (2006), vol. 176, pages 346 - 356-
DESCRIPTION- HOLLIGER ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1993), vol. 90, pages 6444 - 6448-
DESCRIPTION- HOLLIGER; WINTER, CURRENT OPINION BIOTECHNOL., (1993), vol. 4, pages 446 - 449-
DESCRIPTION- HU ET AL., CANCER RES., (1996), vol. 56, pages 3055 - 3061-
DESCRIPTION- HUSTON ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1988), vol. 85, pages 5879 - 5883-
DESCRIPTION- HYMOWITZ ET AL., J. BIOL. CHEM., (2005), vol. 280, page 7218-
DESCRIPTION- ICHIKI ET AL., J. IMMUNOL., (1993), vol. 150, pages 5408 - 5417-
DESCRIPTION- JAMES ET AL., J MOL BIOL, (1999), vol. 289, pages 293 - 301-
DESCRIPTION- JEFFERIS ET AL., IMMUNOL LETT, (2002), vol. 82, pages 57 - 65-
DESCRIPTION- JOHNSON; WU, NUCLEIC ACIDS RES., (2000), vol. 28, pages 214 - 218-
DESCRIPTION- JOHNSON; WU, NUCLEIC ACIDS RES., (2001), vol. 29, pages 205 - 206-
DESCRIPTION- JONES ET AL., NATURE, (1986), vol. 321, pages 522 - 525-
DESCRIPTION- JONES, NATURE, (1986), vol. 321, pages 522 - 525-
DESCRIPTION- JUNGBLUTH ET AL., PROC NATL ACAD SCI USA., (2003), vol. 100, no. 2, pages 639 - 44-
DESCRIPTION- J. W. CHIN ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (2002), vol. 124, pages 9026 - 9027-
DESCRIPTION- J. W. CHIN ET AL., PICAS UNITED STATES OF AMERICA, (2002), vol. 99, pages 11020 - 11024-
DESCRIPTION- J. W. CHIN; P. G. SCHULTZ, CHEMBIOCHEM, (2002), vol. 11, pages 1135 - 1137-
DESCRIPTION- KETTLEBOROUGH ET AL., PROTEIN ENG., (1991), vol. 4, no. 7, pages 773 - 83-
DESCRIPTION- KRAPP ET AL., J MOL BIOL, (2003), vol. 325, pages 979 - 989-
DESCRIPTION- KRAUSS ET AL., PROTEIN ENGINEERING, (2003), vol. 16, no. 10, pages 753 - 759-
DESCRIPTION- KUHLMAN ET AL., SCIENCE, (2003), vol. 302, pages 1364 - 8-
DESCRIPTION- LAZAR ET AL., PROC. NAT. ACAD. SCI USA., (2006), vol. 103, no. 111, pages 4005 - 4010-
DESCRIPTION- LEFRANC ET AL., NUCLEIC ACIDS RES., (1999), vol. 27, pages 209 - 212-
DESCRIPTION- LEFRANC ET AL., NUCLEIC ACIDS RES., (2001), vol. 29, pages 207 - 209-
DESCRIPTION- LEFRANC ET AL., NUCLEIC ACIDS RES., (2003), vol. 31, pages 307 - 310-
DESCRIPTION- LEHRNBECHER ET AL., BLOOD, (1999), vol. 94, pages 4220 - 4232-
DESCRIPTION- LITTLE ET AL., IMMUNOL TODAY, (2000), vol. 21, pages 364 - 370-
DESCRIPTION- L. WANG; P. G. SCHULTZ, CHEM, (2002), pages 1 - 10-
DESCRIPTION- MALLIOS, BIOINFORMATICS, (1999), vol. 15, pages 432 - 439-
DESCRIPTION- MALLIOS, BIOINFORMATICS, (2001), vol. 17, pages 942 - 948-
DESCRIPTION- M.A. MARTI-RENOM ET AL., ANNU. REV. BIOPHYS. BIOMOL. STRUCT., (2000), vol. 29, pages 291 - 325-
DESCRIPTION- MARSHALL ET AL., J. IMMUNOL., (1995), vol. 154, pages 5927 - 5933-
DESCRIPTION- MARTIN AC, PROTEINS, (199605), vol. 25, no. 1, pages 130 - 3-
DESCRIPTION- MARTIN ET AL., MOL CELL, (200104), vol. 7, no. 4, pages 867 - 77-
DESCRIPTION- MARTIN ET AL., MOL CELL, (2001), vol. 7, pages 867 - 877-
DESCRIPTION- MARTIN ET AL., MOLECULAR CELL, (2001), vol. 7, pages 867 - 877-
DESCRIPTION- MATEO ET AL., IMMUNOTECHNOLOGY, (1997), vol. 3, no. 1, pages 71 - 81-
DESCRIPTION- MAXWELL ET AL., NAT STRUCT BIOL, (1999), vol. 6, pages 437 - 442-
DESCRIPTION- MAYNARD, ANNU REV BIOMED ENG, (2000), vol. 2, pages 339 - 376-
DESCRIPTION- MAYNARD; GEORGIOU, ANNU REV BIOMED ENG, (2000), vol. 2, pages 339 - 76-
DESCRIPTION- MCLAUGHLIN ET AL., J CLIN ONCOL, (1998), vol. 16, pages 2825 - 2833-
DESCRIPTION- MEDESAN ET AL., J. IMMUNOL., (1997), vol. 158, no. 5, pages 2211 - 7-
DESCRIPTION- MEDESAN ET AL., J. IMMUNOL., (1997), vol. 158, no. 5, pages 221 - 7-
DESCRIPTION- MIMURA ET AL., J BIOL CHEM, (2001), vol. 276, pages 45539 - 45547-
DESCRIPTION- MODJTAHEDI ET AL., BR J CANCER., (1993), vol. 67, no. 2, pages 247 - 53-
DESCRIPTION- MODJTAHEDI ET AL., BR J CANCER, (1996), vol. 73, no. 2, pages 228 - 35-
DESCRIPTION- MODJTAHEDI ET AL., INT J CANCER, (2003), vol. 105, no. 2, pages 273 - 80-
DESCRIPTION- MODJTAHEDI ET AL., J. CELL BIOPHYS., (1993), vol. 22, no. 1-3, pages 129 - 46-
DESCRIPTION- MOREA, BIOPHYS CHEM, (1997), vol. 68, pages 9 - 16-
DESCRIPTION- MOREA ET AL., METHODS, (2000), vol. 20, pages 267 - 279-
DESCRIPTION- MURTHY ET AL., ARCH BIOCHEM BIOPHYS., (1987), vol. 252, no. 2, pages 549 - 60-
DESCRIPTION- NOLAN ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1988), vol. 85, pages 2603 - 2607-
DESCRIPTION- O'CONNOR ET AL., PROTEIN ENG, (1998), vol. 11, pages 321 - 8-
DESCRIPTION- PENICHET ET AL., J IMMUNOL METHODS, (2001), vol. 248, pages 91 - 101-
DESCRIPTION- PETKOVA ET AL., INTERNATIONAL IMMUNITY, (200612), vol. 18, no. 12, pages 1759 - 69-
DESCRIPTION- PETKOVA ET AL., INTERNATIONAL IMMUNOLOGY, (200612), vol. 18, no. 12, pages 1759 - 69-
DESCRIPTION- PRESTA ET AL., CANCER RES., (1997), vol. 57, no. 20, pages 4593 - 9-
DESCRIPTION- QUEEN ET AL., PROC NATL ACAD SCI, USA, (1989), vol. 86, pages 10029 - 33-
DESCRIPTION- RADAEV ET AL., J BIOL CHEM, (2001), vol. 276, pages 16469 - 16477-
DESCRIPTION- RADAEV ET AL., J BIOL CHEM, (2001), vol. 276, pages 16478 - 16483-
DESCRIPTION- RADAEV S ET AL., J. BIOL. CHEM., vol. 276, pages 16469 - 16477-
DESCRIPTION- RADER ET AL., PROC. NATL. ACAD. SCI. USA, (1998), vol. 95, pages 8910 - 8915-
DESCRIPTION- RAGHAVAN, ANNU REV CELL DEV BIOL, (1996), vol. 12, pages 181 - 220-
DESCRIPTION- RAGHAVAN ET AL., ANNU REV CELL DEV BIOL, (1996), vol. 12, pages 181 - 220-
DESCRIPTION- RAVETCH ET AL., ANNU REV IMMUNOL, (2001), vol. 19, pages 275 - 290-
DESCRIPTION- REITER ET AL., NATURE BIOTECH., (1996), vol. 14, pages 1239 - 1245-
DESCRIPTION- RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 329-
DESCRIPTION- RODECK ET AL., J CELL BIOCHEM., (1987), vol. 35, no. 4, pages 315 - 20-
DESCRIPTION- ROGUSKA ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 969 - 973-
DESCRIPTION- ROQUE ET AL., BIOTECHNOL. PROG., (2004), vol. 20, pages 639 - 654-
DESCRIPTION- ROSOK ET AL., J. BIOL. CHEM., vol. 271, no. 37, pages 22611 - 22618-
DESCRIPTION- RUIZ ET AL., NUCLEIC ACIDS RES., (2000), vol. 28, pages 219 - 221-
DESCRIPTION- SAUER-ERIKSSON ET AL., STRUCTURE, (1995), vol. 3, pages 265 - 278-
DESCRIPTION- SHIELDS ET AL., J. BIOL. CHEM., (2001), vol. 276, no. 9, pages 6591 - 6604-
DESCRIPTION- SHIELDS ET AL., J BIOL CHEM, (2001), vol. 276, pages 6591 - 6604-
DESCRIPTION- SHIELDS ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 6591 - 6604-
DESCRIPTION- SHIELDS ET AL., J BIOL CHEM, (2002), vol. 277, pages 26733 - 26740-
DESCRIPTION- SHIELDS ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, (2001), vol. 276, no. 9, pages 6591 - 6604-
DESCRIPTION- SHINKAWA ET AL., J BIOL CHEM, (2003), vol. 278, pages 3466 - 3473-
DESCRIPTION- SIMMONS ET AL., J IMMUNOL METHODS, (2002), vol. 263, pages 133 - 147-
DESCRIPTION- SIMON ET AL., PNAS USA, (1992), vol. 89, no. 20, page 9367-
DESCRIPTION- SONDERMANN ET AL., EMBO J, (1999), vol. 18, pages 1095 - 1103-
DESCRIPTION- SONDERMANN ET AL., J MOL BIOL, (2001), vol. 309, pages 737 - 749-
DESCRIPTION- SONDERMANN ET AL., NATURE, (2000), vol. 406, page 267-
DESCRIPTION- SONDERMANN ET AL., NATURE, (2000), vol. 406, pages 267 - 273-
DESCRIPTION- SONDERMANN, J MOL BIOL, (2001), vol. 309, pages 737 - 749-
DESCRIPTION- STAUBER, BIOTECHNIQUES, (1998), vol. 24, pages 462 - 471-
DESCRIPTION- STURNIOLO ET AL., NATURE BIOTECH., (1999), vol. 17, pages 555 - 561-
DESCRIPTION- STURNIOLO, NATURE BIOTECH., (1999), vol. 17, pages 555 - 561-
DESCRIPTION- TAN ET AL., J. IMMUNOL., (2002), vol. 169, pages 1119 - 1125-
DESCRIPTION- TASHIRO ET AL., CURR OPIN STRUCT BIOL, (1995), vol. 5, pages 471 - 481-
DESCRIPTION- TECHNICAL SECTION ON CROSS-LINKERS, (1994), pages 155 - 200-
DESCRIPTION- T. E. CREIGHTON, Proteins: Structure and Molecular Properties, W. H. FREEMAN & CO., (1983), pages 79 - 86-
DESCRIPTION- THOTAKURA ET AL., METH. ENZYMOL., (1987), vol. 138, page 350-
DESCRIPTION- TOMLINSON, METHODS ENZYMOL., (2000), vol. 326, pages 461 - 479-
DESCRIPTION- TSURUSHITA; VASQUEZ, Humanization of Monoclonal Antibodies, Molecular Biology of B Cells, ELSEVIER SCIENCE (USA, (2004), pages 533 - 545-
DESCRIPTION- UMANA ET AL., NAT BIOTECHNOL, (1999), vol. 17, pages 176 - 180-
DESCRIPTION- VAN HOLDE; JOHNSON; HO, Principles of Physical Biochemistry, PRENTICE HALL, (1998), page 78-
DESCRIPTION- VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536-
DESCRIPTION- WARD ET AL., NATURE, (1989), vol. 341, pages 544 - 546-
DESCRIPTION- WU ET AL., J. MOL. BIOL., (1999), vol. 294, pages 151 - 162-
DESCRIPTION- YOSHIDA ET AL., IMMUNITY, (2004), vol. 20, no. 6, pages 769 - 783-
DESCRIPTION- ZHANG ET AL., PROC NATL ACAD SCI USA, (2003), vol. 303, no. 5656, pages 371 - 3-
OPPOSITION- ZALEVSKY, JONATHAN et al., "Enhanced antibody half-life improves in vivo activity", Nature biotechnology, (20100000), vol. 28, no. 2, doi:10.1038/nbt.1601, pages 157 - 159, XP055308991
OPPOSITION- ROOPENIAN DERRY C, ET AL, "FcRn: the neonatal Fc receptor comes of age.", Nature Reviews Immunology, Nature Publishing Group UK, London, London, (20070901), vol. 7, no. 9, doi:10.1038/NRI2155, ISSN 1474-1733, pages 715 - 725, XP002510057
OPPOSITION- HINTON, PAUL R. et al., "Engineered human IgG antibodies with longer serum half-lives in primates", Journal of Biological Chemistry, (20040000), vol. 279, no. 8, doi:10.1074/jbc.C300470200, pages 6213 - 6216, XP002482523
SEARCH- JONATHAN ZALEVSKY ET AL, "Enhanced antibody half-life improves in vivo activity", NATURE BIOTECHNOLOGY, (20100201), vol. 28, no. 2, doi:10.1038/nbt.1601, ISSN 1087-0156, pages 157 - 159, XP055049187 [T] 1-10 * page 157, column r, paragraph 1 - paragraph 2 *
SEARCH- HINTON P R ET AL, "Engineered human IgG antibodies with longer serum half-lives in primates", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (20040220), vol. 279, no. 8, doi:10.1074/JBC.C300470200, ISSN 0021-9258, pages 6213 - 6216, XP002305813 [I] 1-10 * abstract * * page 6215, column l, paragraph 1 *
SEARCH- PETKOVA STEFKA B ET AL, "Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease", INTERNATIONAL IMMUNOLOGY, OXFORD UNIVERSITY PRESS, GB, (20061201), vol. 18, no. 12, doi:10.1093/INTIMM/DXL110, ISSN 0953-8178, pages 1759 - 1769, XP002539987 [A] 1-10 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents